top of page

Last Updated: June, 2024

PIPELINE SCANNER

Diabetes, Obesity & Endocrinology Pipeline

Notes:

  • Coverage includes 70+ leading biopharma companies globally across all therapeutic areas

  • Where available, forecast to 2028 sales cover all trials across all indications for drug 

  • All non-US company sales converted to USD

  • Phase I drugs are not included for Merck & Co.

​

Source: Company Websites, Company Investor Presentations, ClinicalTrials.gov, PharmaSights Analysis

ADDITIONAL PIPELINES AVAILABLE

Oncology & Malignant Hematology

OMH Pipeline.png

Immunology, GI & Dermatology

IGD Pipeline.png

Musculoskeletal

Musculoskeletal Pipeline.png

Cardiovascular

Cardiovascular Pipeline.png

Vaccines

Vaccines Pipeline.png

Respiratory

Respiratory Pipeline.png

Central Nervous System (CNS) & Pain

CP Pipeline.png

Non-Malignant Hematology

NMH Pipeline.png

Infectious Diseases

Infectious Diseases Pipeline.png

Ophthalmology

Opthalmology Pipeline.png

Women's, Genitourinary & Nephrology

WGN Pipeline.png

Rare Diseases

Rare Diseases Pipeline.png
bottom of page